IOL Chemicals and Pharmaceuticals Limited (IOLCP.BO)
- Previous Close
402.00 - Open
398.25 - Bid 399.95 x --
- Ask 400.20 x --
- Day's Range
394.00 - 405.05 - 52 Week Range
350.30 - 535.60 - Volume
24,133 - Avg. Volume
32,296 - Market Cap (intraday)
23.453B - Beta (5Y Monthly) 0.73
- PE Ratio (TTM)
13.68 - EPS (TTM)
29.20 - Earnings Date Apr 29, 2024 - May 3, 2024
- Forward Dividend & Yield 5.00 (1.25%)
- Ex-Dividend Date Feb 16, 2024
- 1y Target Est
76.00
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, and anti-cholelithic, as well as proton pump inhibitor. The company also provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, para amino phenol, and mono chloro acetic acid to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.
www.iolcp.com2,569
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: IOLCP.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IOLCP.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IOLCP.BO
Valuation Measures
Market Cap
23.45B
Enterprise Value
23.29B
Trailing P/E
13.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.07
Price/Book (mrq)
1.48
Enterprise Value/Revenue
1.06
Enterprise Value/EBITDA
7.71
Financial Highlights
Profitability and Income Statement
Profit Margin
7.74%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
22.16B
Net Income Avi to Common (ttm)
1.72B
Diluted EPS (ttm)
29.20
Balance Sheet and Cash Flow
Total Cash (mrq)
614.1M
Total Debt/Equity (mrq)
3.71%
Levered Free Cash Flow (ttm)
--
Research Analysis: IOLCP.BO
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: IOLCP.BO
IOLCP.BO does not have Company Insights